Shattuck Labs (STTK) Other financing activities (2020 - 2024)

Shattuck Labs (STTK) reported Other financing activities of $356000.0 for Q1 2024, up 141.2% quarter-over-quarter from -$864000.0 in Q4 2020.

Shattuck Labs (STTK) Other financing activities (2020 - 2024) Analysis & Trends

Shattuck Labs (STTK) has 2 years of Other financing activities data on file, last reported at $356000.0 in Q1 2024.

Other financing activities for Q1 2024 came in at $356000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $356000.0 (up 170.08% YoY), and the FY2024 annual result was $17000.0, changed N/A from the prior year.
Other financing activities climbed to $356000.0 in Q1 2024 per STTK's latest filing, from -$864000.0 in the prior quarter.
Over five years, Other financing activities peaked at $1.1 million in Q3 2020 and troughed at -$864000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Shattuck Labs	190.32 Mn	190.32 Mn	-

Download Data